Delayed diagnosis of fibrotic ILD leads to higher mortality rates and shorter overall survival, emphasizing the need for early clinical recognition. Supplemental oxygen therapy in fibrotic ILD ...

日本光電はこの度、当社初の NPPV（非侵襲的陽圧換気）（※1）を行う「NKV-330 人工呼吸器」を発売しました。これまで培ってきた HMI（Human Machine Interface）（※2）技術や生体情報モニタリング技術を融合し、医療現場の困りごとを解決するために開発した製品 ...

Patients with fibrosing interstitial lung disease (ILD) who began supplemental oxygen therapy had triple the per patient per month ILD-related health care costs compared with those who did not.

NATROX® O2 is a wearable medical device designed to continuously deliver topical oxygen directly to a wound to promote and enhance healing. ROCKVILLE, MD, UNITED STATES, September 10, 2025 ...